Patents Assigned to The United States of America, as represented by the Secretary Department of Health by Human Servies
  • Methods of treating and preventing inflammatory bowel disease involving IL-13 and NKT cells
    Patent number: 9072716
    Abstract: The present invention provides a method of treating or preventing the inflammatory response of ulcerative colitis or Crohn's disease in a subject comprising administering to the subject an effective amount of a substance that inhibits the binding of IL-13 to IL-13 receptors on NKT cells or delivers an effector molecule to the NKT cells.
    Type: Grant
    Filed: April 14, 2006
    Date of Patent: July 7, 2015
    Assignee: The United States of America, as represented by the Secretary Department of Health by Human Servies
    Inventors: Warren Strober, Ivan Fuss, Peter Mannon, Jan Preiss, Raj Puri, Koji Kawakami, Stefan Fichtner-Feigl, Atsushi Kitani